Table 2 Spearman correlation coefficients between AR expression and serum FSH and LH levels in regrouped non-PCOM and PCOM subgroups.
From: Role of Androgen Receptor for Reconsidering the “True” Polycystic Ovarian Morphology in PCOS
Threshold of FNPO | non-PCOM | PCOM | ||||||
|---|---|---|---|---|---|---|---|---|
FSH, IU/L | LH, IU/L | FSH, IU/L | LH, IU/L | |||||
r | p | r | p | r | p | r | p | |
12 | 0.553* | 0.000 | 0.024 | 0.871 | −0.099 | 0.454 | −0.290* | 0.026 |
20 | 0.238* | 0.025 | −0.101 | 0.347 | −0.273 | 0.288 | −0.515* | 0.034 |
21 | 0.223* | 0.030 | −0.109 | 0.296 | −0.266 | 0.404 | −0.762* | 0.004 |
22 | 0.212* | 0.038 | −0.136 | 0.188 | −0.455 | 0.187 | −0.648* | 0.043 |
23 | 0.210* | 0.039 | −0.141 | 0.167 | −0.500 | 0.170 | −0.700* | 0.036 |
24 | 0.193 | 0.055 | −0.155 | 0.125 | −0.321 | 0.482 | −0.536 | 0.215 |
26 | 0.179 | 0.074 | −0.170 | 0.090 | 0.000 | 1.000 | −0.300 | 0.624 |
